Business

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16–19, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15–18, 2025, in Philadelphi

articleOragenics Inc.June 10, 20251/company/oragenics-inc/news/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

About this update from Oragenics Inc.

[{"type":"image","alt":"Oragenics","displaySize":"","headline":null,"caption":"Oragenics","className":"","disableSlideshowImg":false,"size":{"original":{"width":256,"height":256,"url":"https://media.zenfs.com/en/globenewswire.com/0212681d7f415be924a60d8016c09110"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ol2bqPWKKXmUHXexVg71mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0212681d7f415be924a60d8016c09110","width":256,"height":256}},"lazy":false},{"type":"text","content":"SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16–19, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15–18, 2025, in Philadelphia, Pennsylvania.","length":516,"tagName":"p"},{"type":"text","content":"These back-to-back events represent key opportunities for Oragenics to highlight its lead candidate, ONP-002, an intranasal neurosteroid in development for the treatment of concussion (mild traumatic brain injury), and to engage with global leaders in neuroscience, neurology, biotech, and pharma.","length":297,"tagName":"p"},{"type":"text","content":"2025 BIO International Convention","length":33,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dates: June 16–19, 2025","length":23,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Boston Convention & Exhibition Center, Boston, MA","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation Date & Time: June 19, 2025, from 11:30 AM – 11:45 AM ET","length":72,"tagName":"p"}]},{"val":[{"type":"text","content":"Registration: https://www.bio.org/events/bio-international-convention/registration","length":82,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":240,"olType":false},{"type":"text","content":"42nd Annual National Neurotrauma Society (NNS) Symposium","length":56,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dates: June 15–18, 2025","length":23,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Philadelphia Marr...

More updates from Oragenics Inc.

Oragenics, Inc.OragenicsInternational Conventionmild traumatic brain injurybiotechnology companyNNSPhiladelphia Marriott DowntownBoston Convention & Exhibition CenterNeurotrauma